Recent advances in genetics of bipolar disorder

Bipolar Disorder: The Upswing in Research and Treatment

Volumn , Issue , 2005, Pages 77-92

  Müller, Daniel J ^a,b   Kennedy, James L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925636500     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (66)

1. Smoller JW, Finn CT, Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 2003; 123:48–58.
2. Belmaker RH, Bipolar disorder. N Engl J Med 2004; 351:476–486.
3. Petronis A, Epigenetics and bipolar disorder: new opportunities and challenges. Am J Med Genet C Semin Med Genet 2003; 123:65–75.
4. Kelsoe JR, Arguments for the genetic basis of the bipolar spectrum. J Affect Disord 2003; 73:183–197.
5. Tsuang MT, Taylor L, Faraone SV, An overview of the genetics of psychotic mood disorders. J Psychiatr Res 2004; 38:3–15.
6. Alda M, Pharmacogenetic aspects of bipolar disorder. Pharmacogenomics 2003; 4:35–40.
7. Duan J, Wainwright MS, Comeron JM et al, Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003; 12:205–216.
8. Sklar P, Linkage analysis in psychiatric disorders: the emerging picture. Annu Rev Genomics Hum Genet 2002; 3:371–413.
9. Schulze TG, McMahon FJ, Genetic linkage and association studies in bipolar affective disorder: a time for optimism. Am J Med Genet C Semin Med Genet 2003; 123:36–47.
10. Lander ES, Kruglyak L, Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11:241–247.
11. Craddock N, Dave S, Greening J, Association studies of bipolar disorder. Bipolar Disord 2001; 3:284–298.
12. Gershon ES, Kelsoe JR, Kendler KS, Watson JD, A scientific opportunity. Science 2001; 294:957.
13. Fortune MT, Kennedy JL, Vincent JB, Anticipation and CAG*CTG repeat expansion in schizophrenia and bipolar affective disorder. Curr Psychiatry Rep 2003; 5:145–154.
14. Baron M, Manic-depression genes and the new millennium: poised for discovery. Mol Psychiatry 2002; 7:342–358.
15. Cichon S, Schumacher J, Muller DJ et al, A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 2001; 10:2933–2944.
16. McMahon FJ, Stine OC, Meyers DA et al, Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet 1995; 56:1277–1286.
17. Gershon ES, Badner JA, Detera-Wadleigh SD et al, Maternal inheritance and chromosome 18 allele sharing in unilineal bipolar illness pedigrees. Am J Med Genet 1996; 67:202–207.
18. Nothen MM, Cichon S, Rohleder H et al, Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry 1999; 4:76–84.
19. McInnis MG, Lan TH, Willour VL et al, Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12. Mol Psychiatry 2003; 8:288–298.
20. Segurado R, Detera-Wadleigh SD, Levinson DF et al, Genome scan metaanalysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 2003; 73:49–62.
21. Badner JA, Gershon ES, Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7:405–411.
22. Risch N, Merikangas K, The future of genetic studies of complex human diseases. Science 1996; 273:1516–1517.
23. Kirov G, Norton N, Jones I et al, A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. Int J Neuropsychopharmacol 1999; 2:293–298.
24. Kunugi H, Ishida S, Kato T et al, A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 1999; 4:393–395.
25. Preisig M, Bellivier F, Fenton BT et al, Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am J Psychiatry 2000; 157:948–955.
26. Ho LW, Furlong RA, Rubinsztein JS et al, Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 2000; 96:36–42.
27. Mundo E, Walker M, Tims H et al, Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder. Am J Med Genet 2000; 96:379–383.
28. Jones I, Craddock N, Candidate gene studies of bipolar disorder. Ann Med 2001; 33:248–256.
29. Rotondo A, Mazzanti C, Dell’Osso L et al, Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry 2002; 159:23–29.
30. Gutierrez B, Arias B, Gasto C et al, Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatr Genet 2004; 14:203–208.
31. Mendlewicz J, Massat I, Souery D et al, Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study. Eur J Hum Genet 2004; 12:377–382.
32. Lasky-Su JA, Faraone SV, Glatt SJ, Tsuang MT, Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am J Med Genet B Neuropsyhchiatr Genet 2005; 133:110–115.
33. Muglia P, Petronis A, Mundo E et al, Dopamine D4 receptor and tyrosine hydroxylase genes in bipolar disorder: evidence for a role of DRD4. Mol Psychiatry 2002; 7:860–866.
34. Chumakov I, Blumenfeld M, Guerassimenko O et al, Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99:13675–13680.
35. Mundo E, Tharmalingham S, Neves-Pereira M et al, Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol Psychiatry 2003; 8:241–245.
36. Sivagnansundaram S, Müller DJ, Gubanov A et al, Genetics of schizophrenia: Current strategies. Clin Neurosci Res 2003; 3:5–16.
37. Berrettini W, Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet C Semin Med Genet 2003; 123:59–64.
38. Hattori E, Liu C, Badner JA et al, Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet 2003; 72:1131–1140.
39. Chen YS, Akula N, Detera-Wadleigh SD et al, Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33. Mol Psychiatry 2004; 9:87–92; image 5.
40. Schumacher J, Jamra RA, Freudenberg J et al, Examination of G72 and Damino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 2004; 9:203–207.
41. Hanson IM, Seawright A, van Heyningen V, The human BDNF gene maps between FSHB and HVBS1 at the boundary of 11p13-p14. Genomics 1992; 13:1331–1333.
42. Detera-Wadleigh SD, Badner JA, Berrettini W et al, A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999; 96:5604–5609.
43. Zandi PP, Willour VL, Huo Y et al, Genome scan of a second wave of NIMH genetics initiative bipolar pedigrees: chromosomes 2, 11, 13, 14, and X. Am J Med Genet B Neuropsychiatr Genet 2003; 119:69–76.
44. Green E, Craddock N, Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: evidence, limitations, and implications. Curr Psychiatry Rep 2003; 5:469–476.
45. Lyons WE, Mamounas LA, Ricaurte GA et al, Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 1999; 96:15239–15244.
46. Fukumoto T, Morinobu S, Okamoto Y et al, Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 2001; 158:100–106.
47. Chen B, Dowlatshahi D, MacQueen GM et al, Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50:260–265.
48. Dwivedi Y, Rizavi HS, Conley RR et al, Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003; 60:804–815.
49. Shimizu E, Hashimoto K, Okamura N et al, Alterations of serum levels of brainderived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54:70–75.
50. Nakata K, Ujike H, Sakai A et al, Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003; 337:17–20.
51. Hall D, Dhilla A, Charalambous A et al, Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive– compulsive disorder. Am J Hum Genet 2003; 73:370–376.
52. Egan MF, Kojima M, Callicott JH et al, The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112:257–269.
53. Neves-Pereira M, Mundo E, Muglia P et al, The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a familybased association study. Am J Hum Genet 2002; 71:651–655.
54. Sklar P, Gabriel SB, McInnis MG et al, Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brainderived neutrophic factor. Mol Psychiatry 2002; 7:579–593.
55. Schulze TG, Hardy J, McMahon FJ, Inconsistent designs of association studies: a missed opportunity. Mol Psychiatry 2003; 8:770–772.
56. Geller B, Badner JA, Tillman R et al, Linkage disequilibrium of the brainderived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004; 161:1698–1700.
57. Hong CJ, Huo SJ, Yen FC et al, Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48:186–189.
58. Kunugi H, Iijima Y, Tatsumi M et al, No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry 2004; 56:376–378.
59. Skibinska M, Hauser J, Czerski PM et al, Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry 2004; 5:215–220.
60. Neves-Pereira M, Cheung JK, Pasdar A et al, BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005; 10:208–212.
61. Cichon S, Schumacher J, Abou Jamra R et al, Supportive evidence for a relationship between genetic variations at the brain-derived-neurotrophic factor (BDNF) locus and depressive symptoms in affective disorder and schizophrenia. Am J Hum Genet (Neuropsych Genet) 2004; 130B:27.
62. Strauss J, Barr CL, George CJ et al, Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet 2004; 131B:16–19.
63. Müller DJ, De Luca V, Sicard T et al, ‘Rapid cycling’ mainly determines significant findings between the BDNF gene and bipolar disorder. Am J Hum Genet (Neuropsych Genet) 2004; 130B:45.
64. Muglia P, Vicente AM, Verga M et al, Association between the BDNF gene and schizophrenia. Mol Psychiatry 2003; 8:146–147.
65. Lanktree M, Muglia P, Squassina A et al, A potential role for brain derived neurotrophic factor (BDNF) in adult ADHD. Am J Hum Genet (Neuropsych Genet) 2004; 130B:96.
66. Schulze TG, Muller DJ, Krauss H et al, Caught in the trio trap? Potential selection bias inherent to association studies using parent–offspring trios. Am J Med Genet 2001; 105:351–353.